Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
09/2005
09/22/2005CA2560209A1 Tissue repair
09/22/2005CA2560111A1 Aminophenylpropanoic acid derivative
09/22/2005CA2560098A1 2-aminoquinazoline derivative
09/22/2005CA2556223A1 Synergistic effect of compositions comprising carotenoids selected from lutein, beta-carotene and lycopene
09/21/2005EP1577323A1 Metastin derivative and use thereof
09/21/2005EP1577317A1 Nitrogen-containing heterocycic derivatives, medicinal compositions containing the same and medicinal use thereof
09/21/2005EP1577309A1 Optically active dihydropyridine derivative
09/21/2005EP1577302A1 Novel ethylenediamine derivatives
09/21/2005EP1577299A1 Alkynyl-substituted azasugar derivative and drug containing the same as the active ingredient
09/21/2005EP1577288A1 Selective estrogen receptor modulators
09/21/2005EP1576964A1 Protease inhibitor
09/21/2005EP1576960A1 Composition containing green and yellow vegetables and light-colored vegetables
09/21/2005EP1576955A1 Combinatorial therapy with an acetylcholinesterase inhibitor and (3aR) 1,3a,8 trimethyl 1,2,3,3a,8,8a hexahydropyrrolo[2,3 b]indol 5 yl phenylcarbamate
09/21/2005EP1576954A1 Preferential inhibition of release of pro-inflammatory cytokines
09/21/2005EP1576893A1 Composition containing isoflavone of high purity at high concentration and process for producing the same
09/21/2005EP1576089A2 Expansion of renewable stem cell populations
09/21/2005EP1576010A2 Compositions and methods of therapy for cancers characterized by expression of the tumor-associated antigen mn/ca ix
09/21/2005EP1575934A1 Carbazole derivatives and their use as npy-5 antagonists
09/21/2005EP1575916A2 Phosphodiesterase activity and regulation of phosphodiesterase 1-b-mediated signaling in brain
09/21/2005EP1575903A1 Compounds for the inhibition of rotamases
09/21/2005EP1575658A2 Screening and therapeutic methods for treating circadian rhythm disorders
09/21/2005EP1575552A2 Metal-containing materials, compositions and methods
09/21/2005EP1575528A2 Tissue protective cytokines for the protection, restoration, and enhancement of responsive cells, tissues and organs
09/21/2005EP1575524A2 Proliferated cell lines and uses thereof
09/21/2005EP1575499A2 Mammalian epo mimetic ch1 deleted mimetibodies, compositions, methods and uses
09/21/2005EP1575494A2 Engineering absorption of therapeutic compounds via colonic transporters
09/21/2005EP1575486A2 Method and compositions for identifying anti-hiv therapeutic compounds
09/21/2005EP1575480A2 Compositions and methods for the treatment of immune related diseases
09/21/2005EP1575416A2 Methods of diagnosing and treating pre-eclampsia or eclampsia
09/21/2005EP1435965A4 Pharmaceutical compositions and methods for treating cancer
09/21/2005EP1420790B1 Use of bibn4096 in combination with other antimigraine drugs for the treatment of migraine
09/21/2005EP1401463B1 Compositions comprising thylakoids useful in the modulation of the inflammation process
09/21/2005EP1377560B1 Piperazine derivatives as tachykinin antagonists
09/21/2005EP1282602B1 Propanoic acid derivatives as integrin receptor antagonists
09/21/2005EP1263446B1 Mixture comprising an inhibitor or suppressor of a gene and a molecule binding to an expression product of that gene
09/21/2005EP1220857B1 Gonadotropin releasing hormone receptor antagonists and their related methods of use
09/21/2005EP1137640B1 Cyclic hydrazine derivatives as tnf-alpha inhibitors
09/21/2005EP1129188B1 Pge synthase and methods and means for modulating its activity
09/21/2005EP1019533B1 Silanol enzyme inhibitors
09/21/2005EP0994710B2 Pharmaceutical compositions for oral administration, comprising a benzhydrylpiperazine and a cyclodextrin
09/21/2005EP0792364B1 Lgmd gene coding for a calcium dependent protease
09/21/2005EP0776337B1 Growth differentiation factor-11
09/21/2005EP0712303B1 Skin patches comprising testosterone and optionally estrogen
09/21/2005CN1671863A Central airway administration for systemic delivery of therapeutics
09/21/2005CN1671856A Novel physiologically active substances
09/21/2005CN1671744A Low molecular weight oversulfated polysaccharide
09/21/2005CN1671742A Use of HMGB1 in the treatment of tissue damage and/or to promote tissue repair
09/21/2005CN1671734A CFTR modifier genes and expressed polypeptides useful in treating cystic fibrosis and methods and products for detecting and/or identifying same
09/21/2005CN1671724A Prodrug, medicinal utilization thereof and process for producing the same
09/21/2005CN1671716A Method of treating ischemia reperfusion injury using adenosine receptor antagonists
09/21/2005CN1671715A Arylamine substututed bicyclic heteroaromatic compounds as p38 kinase inhibitors
09/21/2005CN1671714A Benzofused heterozryl amide derivatives of thienopyridines useful as therapeutic agents, pharmaceutical compositions including the same, and methods for their use
09/21/2005CN1671713A Novel derivative of flavone c-glycoside and composition containing the same
09/21/2005CN1671708A Novel derivatives of cycloalcanodiones, method for the production thereof and their pharmacological applications
09/21/2005CN1671701A Novel aryllimidazole derivatives, preparation and therapeutic used thereof
09/21/2005CN1671700A Substituted alkylamine derivatives and methods of use
09/21/2005CN1671696A 激酶抑制剂 Kinase inhibitors
09/21/2005CN1671694A Bisindolyl-maleimid derivatives as kinase inhibitors
09/21/2005CN1671682A Azulene derivatives and salts thereof
09/21/2005CN1671668A 4-(substituted aryl)-5-hydroxyisoquinolinone derivative
09/21/2005CN1671662A Piperidine derivative, process for producing the same, and use
09/21/2005CN1671660A 3-z-[1-(4-(n-((4-methyl-piperazin-1-yl)-methylcarbonyl)-n-methyl-amino)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone-monoethanesulphonate and the use thereof as a pharmaceutical composi
09/21/2005CN1671659A Novel substituted indoles
09/21/2005CN1671639A Novel biphenyl and biphenyl-like cannabinoids
09/21/2005CN1671435A Medicament dispenser
09/21/2005CN1671421A Inclusion complexes of rosiglitazone
09/21/2005CN1671407A Compositions and methods for treating diabetes
09/21/2005CN1671403A Dioxin elimination promoter
09/21/2005CN1671399A Myocardial perfusion imaging using A2A receptor agonists
09/21/2005CN1671396A Medicinal composition for periodontal pocket administration containing bisphosphonic acid derivative or its salt as the active ingredient
09/21/2005CN1671392A Use of a specific cyclic amine derivative or the pharmaceutically acceptable salts thereof for the treatment or prevention of heart failure
09/21/2005CN1671390A Adenosine A2A receptor antagonists for treating restless legs syndrome or related disorders
09/21/2005CN1671388A Sustained-release tablet composition comprising a dopamine receptor agonist
09/21/2005CN1671387A Aryl substituted hydantoin compounds and their use as sodium channel blockers
09/21/2005CN1671386A Substituted anilinic piperidines as MCH selective antagonists
09/21/2005CN1671384A Methods of treating microbial infections in humans and animals
09/21/2005CN1671382A Sustained-release tablet composition of pramipexole
09/21/2005CN1671381A Pramipexole once-daily dosage form
09/21/2005CN1671378A Compounds useful for the treatment of diseases responsive to antiangiogenetic therapy
09/21/2005CN1671376A Composition comprising a cholesterol absorption inhibitor, an HMG-CoA reductase inhibitor and a stabilizing agent
09/21/2005CN1671375A Improved transdermal delivery system for the administration of rotigotine
09/21/2005CN1671372A Food improving blood flow
09/21/2005CN1671371A Combination of an aromatase inhibitor with a bisphosphonate
09/21/2005CN1671365A Improved transdermal delivery system
09/21/2005CN1670217A Process for the preparation of pseudomonic acid A antibiotic by microbiological method
09/21/2005CN1670009A Propynyl or dienyl biaromatic compounds
09/21/2005CN1219780C Heterocyclic compounds binding chemotactic factor receptor
09/21/2005CN1219777C Thiophene vitamine A
09/21/2005CN1219776C Thiophene substituted amine derivatives as GLYT-1 inhibitors
09/21/2005CN1219768C Quinoline derivatives as inhibitors of MEK enzymes
09/21/2005CN1219764C W-carboxyaryl substituted diphenyl ureas as RAF kinase inhibitors
09/21/2005CN1219763C Substituted indole mannich bases
09/21/2005CN1219556C The use of 4-H-1-benzopyran-4-one derivatives as inhibitors of smooth muscle cell proliferation
09/21/2005CN1219542C Chinese medicine for delaying senility and the preparation process of the granule
09/21/2005CN1219534C Fat reducing anti-senility health product
09/21/2005CN1219522C Hard capsule of superfine notoginseng powder
09/21/2005CN1219514C Oral medicine preparation with high absorbency
09/21/2005CN1219512C Pharmaceutical compositions containing oxapenem-3-carboxylic acids
09/21/2005CN1219510C Benzimidazole derivatives as modulators of IgE
09/21/2005CN1219509C Use of rosmarinic acid and derivatives thereof as immunosuppressant or inhibitor of SHz-mediated process
1 ... 466 467 468 469 470 471 472 473 474 475 476 477 478 479 480 481 482 483 484 485 486 ... 1564